Market Cap 160.02M
Revenue (ttm) 0.00
Net Income (ttm) -90.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,026,032
Avg Vol 2,561,796
Day's Range N/A - N/A
Shares Out 217.00M
Stochastic %K 32%
Beta 2.83
Analysts Strong Sell
Price Target $9.33

Company Profile

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacet...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 825 6990
Address:
171 Oyster Point Boulevard, Suite 500, South San Francisco, United States
BIOVIC
BIOVIC Aug. 12 at 8:05 PM
portfolio update. closed $1,329,553 +46,953 (+3.66%). drawdown down to -14.85% from -17.86% yesterday. clawing back real ground $TNYA .76 +1.62 tagged .79, second higher high day post canaccord. $SLNH 1.35 +6.30 closed near day high 1.38, no chop just bid. both doing work q4 catalyst stack intact. HODL. #biovic nfa
1 · Reply
BIOVIC
BIOVIC Aug. 12 at 8:01 PM
$TNYA EOD tape: $TNYA .76 +1.62% vol 2.11M (~76% of avg), day range .75-.79. New high .79 tagged (yesterday .77). Faded off high into close but held green, closed above .75 support. Second consecutive higher-high day. XBI 159.34 +0.80% — sector supportive. Read: TNYA printing higher highs two days running (.77 → .79) but the fades are annoying. Bulls kept control (green close, held .75, took out .77 resistance). Bears got the fade off the highs both days. Volume finally normalizing to ~76% of avg vs 66% yesterday — buyers showing up more. .80 tested via .79 wick, needs one more push. EOD post:
0 · Reply
Raumerica
Raumerica Aug. 12 at 4:36 PM
$TNYA Sure Spinaroonie… Yet another alias for the board clown. Confirmed… she is so pathetic! lol
1 · Reply
Minecraftbeers
Minecraftbeers Aug. 12 at 3:41 PM
$TNYA I got on IG and saw this ad for the first time. It’s an ad to “Access Our Heart Failure Treatment Guide” and learn more about heart failure at Cleveland Clinic in Ohio… the same exact clinic that does all the trials and studies for $TNYA! So they are doing social media out reach for the studies which is good.
2 · Reply
dcrmia
dcrmia Aug. 12 at 3:24 PM
$TNYA Why invest in TNYA
0 · Reply
Tarheel_Trader
Tarheel_Trader Aug. 12 at 2:32 PM
$TNYA push !!!!
0 · Reply
Rolfthewild
Rolfthewild Aug. 12 at 2:29 PM
$TNYA 👀
0 · Reply
lilsilli301
lilsilli301 Aug. 12 at 2:16 PM
0 · Reply
Mainmeister90
Mainmeister90 Aug. 12 at 1:56 PM
$TNYA bought 1 or 2 more shares… hit a milestone, not posting it so it isn’t scraped up. Guesses are welcome. I liked what EHG had to say. And it seems like he’s a good fit based off of his communication yesterday. Why wouldnt I be bullish?
1 · Reply
Damage111
Damage111 Aug. 12 at 1:47 PM
0 · Reply
Latest News on TNYA
Tenaya Therapeutics reports Q2 EPS (20c), consensus (7c)

2026-08-05T21:25:41.000Z - 6 days ago

Tenaya Therapeutics reports Q2 EPS (20c), consensus (7c)


Tenaya Therapeutics Quarterly report: Q2 2026

Aug 5, 2026, 4:00 PM EDT - 7 days ago

Tenaya Therapeutics Quarterly report: Q2 2026


Tenaya Therapeutics Earnings release: Q2 2026

Aug 5, 2026, 4:00 PM EDT - 7 days ago

Tenaya Therapeutics Earnings release: Q2 2026


Tenaya Therapeutics appoints Eric Hyllengren as CFO

2026-06-29T13:01:36.000Z - 6 weeks ago

Tenaya Therapeutics appoints Eric Hyllengren as CFO

ZURA


Tenaya Therapeutics Slides: FY 2026

Jun 4, 2026, 3:10 PM EDT - 2 months ago

Tenaya Therapeutics Slides: FY 2026


Tenaya Therapeutics management to meet with Piper Sandler

2026-06-03T20:45:27.000Z - 2 months ago

Tenaya Therapeutics management to meet with Piper Sandler


Tenaya Therapeutics Transcript: Study result

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Tenaya Therapeutics Transcript: Study result


Tenaya Therapeutics Press release: Study result

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Tenaya Therapeutics Press release: Study result


Tenaya Therapeutics Slides: Study result

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Tenaya Therapeutics Slides: Study result


Tenaya Therapeutics Transcript: Study update

May 15, 2026, 10:30 AM EDT - 3 months ago

Tenaya Therapeutics Transcript: Study update


Tenaya Therapeutics Press release: Study update

May 15, 2026, 10:30 AM EDT - 3 months ago

Tenaya Therapeutics Press release: Study update


Tenaya Therapeutics Slides: Study update

May 15, 2026, 10:30 AM EDT - 3 months ago

Tenaya Therapeutics Slides: Study update


Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c)

2026-05-07T00:34:31.000Z - 3 months ago

Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c)


Tenaya Therapeutics Earnings release: Q1 2026

May 6, 2026, 4:00 PM EDT - 3 months ago

Tenaya Therapeutics Earnings release: Q1 2026


Tenaya Therapeutics Quarterly report: Q1 2026

May 6, 2026, 4:00 PM EDT - 3 months ago

Tenaya Therapeutics Quarterly report: Q1 2026


Tenaya Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Tenaya Therapeutics Proxy statement: Proxy filing


Tenaya Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Tenaya Therapeutics Proxy statement: Proxy filing


Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)

2026-03-11T20:27:09.000Z - 5 months ago

Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)


Tenaya Therapeutics Annual report: Q4 2025

Mar 11, 2026, 4:00 PM EDT - 5 months ago

Tenaya Therapeutics Annual report: Q4 2025


Tenaya Therapeutics Earnings release: Q4 2025

Mar 11, 2026, 4:00 PM EDT - 5 months ago

Tenaya Therapeutics Earnings release: Q4 2025


Tenaya Therapeutics presents preclinical data evaluating TN-301

2026-03-09T12:41:56.000Z - 5 months ago

Tenaya Therapeutics presents preclinical data evaluating TN-301


Tenaya Therapeutics announces 2026 strategic priorities

2026-01-09T13:41:19.000Z - 7 months ago

Tenaya Therapeutics announces 2026 strategic priorities


Tenaya Therapeutics 50M share Spot Secondary priced at $1.20

2025-12-12T07:00:10.000Z - 8 months ago

Tenaya Therapeutics 50M share Spot Secondary priced at $1.20


Tenaya Therapeutics Announces Pricing of Public Offering

Dec 12, 2025, 12:16 AM EST - 8 months ago

Tenaya Therapeutics Announces Pricing of Public Offering


Tenaya Therapeutics Transcript: Study Result

Dec 11, 2025, 5:00 PM EST - 8 months ago

Tenaya Therapeutics Transcript: Study Result


Tenaya Therapeutics Press release: Study Result

Dec 11, 2025, 5:00 PM EST - 8 months ago

Tenaya Therapeutics Press release: Study Result


Tenaya Therapeutics Slides: Study Result

Dec 11, 2025, 5:00 PM EST - 8 months ago

Tenaya Therapeutics Slides: Study Result


Tenaya Therapeutics  files to sell common stock, no amount given

2025-12-11T21:20:52.000Z - 8 months ago

Tenaya Therapeutics files to sell common stock, no amount given


Tenaya Therapeutics Announces Proposed Public Offering

Dec 11, 2025, 4:02 PM EST - 8 months ago

Tenaya Therapeutics Announces Proposed Public Offering


Tenaya Therapeutics Slides: Corporate Presentation

Dec 11, 2025, 7:00 AM EST - 8 months ago

Tenaya Therapeutics Slides: Corporate Presentation


Tenaya Therapeutics Transcript: Status Update

Nov 10, 2025, 8:00 AM EST - 9 months ago

Tenaya Therapeutics Transcript: Status Update


Tenaya Therapeutics Press release: Status Update

Nov 10, 2025, 8:00 AM EST - 9 months ago

Tenaya Therapeutics Press release: Status Update


Tenaya Therapeutics Slides: Status Update

Nov 10, 2025, 8:00 AM EST - 9 months ago

Tenaya Therapeutics Slides: Status Update


Tenaya Therapeutics Earnings release: Q3 2025

Nov 10, 2025, 7:00 AM EST - 9 months ago

Tenaya Therapeutics Earnings release: Q3 2025


Tenaya Therapeutics Quarterly report: Q3 2025

Nov 10, 2025, 7:00 AM EST - 9 months ago

Tenaya Therapeutics Quarterly report: Q3 2025


Tenaya Therapeutics Slides: Corporate Presentation

Sep 9, 2025, 7:00 AM EDT - 1 year ago

Tenaya Therapeutics Slides: Corporate Presentation


Tenaya Therapeutics Transcript: KOL Event

Aug 26, 2025, 11:30 AM EDT - 1 year ago

Tenaya Therapeutics Transcript: KOL Event


Tenaya Therapeutics Slides: Corporate Presentation

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Slides: Corporate Presentation


Tenaya Therapeutics Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Quarterly report: Q2 2025


Tenaya Therapeutics Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Earnings release: Q2 2025


Tenaya Therapeutics Earnings release: Q1 2025

May 7, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Earnings release: Q1 2025


Tenaya Therapeutics Quarterly report: Q1 2025

May 7, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Quarterly report: Q1 2025


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Annual report: Q4 2024

Mar 10, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Annual report: Q4 2024


Tenaya Therapeutics Earnings release: Q4 2024

Mar 10, 2025, 4:00 PM EDT - 1 year ago

Tenaya Therapeutics Earnings release: Q4 2024


Tenaya Therapeutics Transcript: Study Update

Dec 17, 2024, 8:00 AM EST - 1 year ago

Tenaya Therapeutics Transcript: Study Update


Tenaya Therapeutics Press release: Study Update

Dec 17, 2024, 8:00 AM EST - 1 year ago

Tenaya Therapeutics Press release: Study Update


Tenaya Therapeutics Slides: Study Update

Dec 17, 2024, 8:00 AM EST - 1 year ago

Tenaya Therapeutics Slides: Study Update


Tenaya Therapeutics Quarterly report: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Tenaya Therapeutics Quarterly report: Q3 2024


Tenaya Therapeutics Earnings release: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Tenaya Therapeutics Earnings release: Q3 2024


Tenaya Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Quarterly report: Q2 2024


Tenaya Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Earnings release: Q2 2024


Tenaya Therapeutics Announces Research Leadership Updates

Jun 27, 2024, 5:00 PM EDT - 2 years ago

Tenaya Therapeutics Announces Research Leadership Updates


Tenaya Therapeutics Quarterly report: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Quarterly report: Q1 2024


Tenaya Therapeutics Earnings release: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Earnings release: Q1 2024


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2024, 8:00 AM EDT - 2 years ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Proxy statement: Proxy Filing

Apr 17, 2024, 8:00 AM EDT - 2 years ago

Tenaya Therapeutics Proxy statement: Proxy Filing


Tenaya Therapeutics Earnings release: Q4 2023

Mar 18, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Earnings release: Q4 2023


Tenaya Therapeutics Annual report: Q4 2023

Mar 18, 2024, 4:00 PM EDT - 2 years ago

Tenaya Therapeutics Annual report: Q4 2023


BIOVIC
BIOVIC Aug. 12 at 8:05 PM
portfolio update. closed $1,329,553 +46,953 (+3.66%). drawdown down to -14.85% from -17.86% yesterday. clawing back real ground $TNYA .76 +1.62 tagged .79, second higher high day post canaccord. $SLNH 1.35 +6.30 closed near day high 1.38, no chop just bid. both doing work q4 catalyst stack intact. HODL. #biovic nfa
1 · Reply
BIOVIC
BIOVIC Aug. 12 at 8:01 PM
$TNYA EOD tape: $TNYA .76 +1.62% vol 2.11M (~76% of avg), day range .75-.79. New high .79 tagged (yesterday .77). Faded off high into close but held green, closed above .75 support. Second consecutive higher-high day. XBI 159.34 +0.80% — sector supportive. Read: TNYA printing higher highs two days running (.77 → .79) but the fades are annoying. Bulls kept control (green close, held .75, took out .77 resistance). Bears got the fade off the highs both days. Volume finally normalizing to ~76% of avg vs 66% yesterday — buyers showing up more. .80 tested via .79 wick, needs one more push. EOD post:
0 · Reply
Raumerica
Raumerica Aug. 12 at 4:36 PM
$TNYA Sure Spinaroonie… Yet another alias for the board clown. Confirmed… she is so pathetic! lol
1 · Reply
Minecraftbeers
Minecraftbeers Aug. 12 at 3:41 PM
$TNYA I got on IG and saw this ad for the first time. It’s an ad to “Access Our Heart Failure Treatment Guide” and learn more about heart failure at Cleveland Clinic in Ohio… the same exact clinic that does all the trials and studies for $TNYA! So they are doing social media out reach for the studies which is good.
2 · Reply
dcrmia
dcrmia Aug. 12 at 3:24 PM
$TNYA Why invest in TNYA
0 · Reply
Tarheel_Trader
Tarheel_Trader Aug. 12 at 2:32 PM
$TNYA push !!!!
0 · Reply
Rolfthewild
Rolfthewild Aug. 12 at 2:29 PM
$TNYA 👀
0 · Reply
lilsilli301
lilsilli301 Aug. 12 at 2:16 PM
0 · Reply
Mainmeister90
Mainmeister90 Aug. 12 at 1:56 PM
$TNYA bought 1 or 2 more shares… hit a milestone, not posting it so it isn’t scraped up. Guesses are welcome. I liked what EHG had to say. And it seems like he’s a good fit based off of his communication yesterday. Why wouldnt I be bullish?
1 · Reply
Damage111
Damage111 Aug. 12 at 1:47 PM
0 · Reply
dig_THAT_girl
dig_THAT_girl Aug. 12 at 1:35 PM
$TNYA just topped off!
0 · Reply
Minecraftbeers
Minecraftbeers Aug. 12 at 1:35 PM
$TNYA NOV will be big! LFG growth!
0 · Reply
Tarheel_Trader
Tarheel_Trader Aug. 12 at 1:20 PM
$TNYA #LFG!
0 · Reply
BIOVIC
BIOVIC Aug. 12 at 1:15 PM
0 · Reply
Minecraftbeers
Minecraftbeers Aug. 12 at 1:14 PM
0 · Reply
MonteCarrlo
MonteCarrlo Aug. 12 at 12:42 PM
$TNYA dilution for an early stage bio stock is never a good thing. Worst thing that could happen here is R/S followed by dilution. Whochbis a possibility.
2 · Reply
ThesisInvestor
ThesisInvestor Aug. 12 at 5:21 AM
A quick note on $TNYA's ATM, because dilution doesn't necessarily have to be as bad as it sounds. An ATM allows Tenaya to issue new shares and sell them directly into the market when they choose. The important part is that the higher the share price, the fewer shares they need to issue to raise the same amount of cash. For example, to raise $30M: At $0.75 - 40M new shares At $2 - 15M new shares At $3 - 10M new shares At $5 - 6M new shares So if strong Q4 data creates a major move with heavy volume, TNYA could potentially use the ATM to raise significant capital while keeping dilution relatively modest. That's what diluting into strength can look like, create value first, then raise capital at a much better valuation. So at $5 for example, to raise $30M they need 6M new shares, that would increase the share count by about 2.8%.
3 · Reply
ThesisInvestor
ThesisInvestor Aug. 12 at 4:18 AM
$TNYA The updated short interest shows more shorts are closing their positions. Settlement date - Short Interest 07/31/2026 - 21,987,556 07/15/2026 - 24,919,430 06/30/2026 - 26,232,552 06/15/2026 - 28,664,762 05/29/2026 - 29,295,482
0 · Reply
Minecraftbeers
Minecraftbeers Aug. 12 at 2:42 AM
$TNYA if they truly needed money they would utilize the $1 billion in possible milestones. That have that on the table and could focus on that side of the business if truly needed
1 · Reply
Glikin_mouse
Glikin_mouse Aug. 12 at 12:03 AM
$TNYA Late for the party but here is my take: Hyllengren is portraying an executable strategy within capital limitations. As a CFO he doesn’t want to frame the company as a desperate for partnerships and licensing, rather he wants to maintain the messaging of execution and excellence taking no low bids. In my opinion I believe post pivotal alignment for the two lead therapies and phase 2 alignment for tn301 will flip the messaging from moderate capital restraint to deep value opportunity and that’s were he would be set for dealmaking.
1 · Reply
Raumerica
Raumerica Aug. 11 at 11:07 PM
$TNYA I think November 1 to November 12 will be the data readout . AHA conference and 3rd q earnings in this period. AHA November 6-9
1 · Reply
BIOVIC
BIOVIC Aug. 11 at 10:11 PM
$TNYA https://www.investing.com/news/transcripts/tenaya-therapeutics-at-canaccord-genuity-conference-q4-catalysts-loom-93CH-4852359
0 · Reply